Hrt Financial LP Seres Therapeutics, Inc. Transaction History

Hrt Financial LP

$17 Billion
Q2 2024

A detailed history of Hrt Financial LP transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 94,972 shares of MCRB stock, worth $87,374. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,972

Holding current value

$87,374

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.56 - $1.19 $53,184 - $113,016	94,972 New	94,972 $68,000
Q4 2023 Feb 09, 2024	BUY	$0.93 - $2.15 $366,196 - $846,584	393,760 New	393,760 $551,000
Q1 2023 May 12, 2023	BUY	$4.95 - $6.09 $290,371 - $357,245	58,661 New	58,661 $332,000
Q2 2022 Aug 12, 2022	BUY	$2.7 - $7.62 $471,312 - $1.33 Million	174,560 Added 452.27%	213,156 $731,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $2.31 Million - $3.25 Million	-367,399 Reduced 90.49%	38,596 $274,000
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $2.44 Million - $4.64 Million	405,995 New	405,995 $3.38 Million
Q1 2020 May 15, 2020	SELL	$2.64 - $3.82 $31,682 - $45,843	-12,001 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.99 - $4.42 $35,882 - $53,044	12,001 New	12,001 $41,000
Q3 2019 Nov 14, 2019	SELL	$2.29 - $4.16 $29,818 - $54,167	-13,021 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.28 - $7.35 $29,687 - $95,704	13,021 New	13,021 $41,000

Others Institutions Holding MCRB

# of Institutions

Shares Held

46.3M

Call Options Held

119K

Put Options Held

466K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$21.3 Million
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

6.29M
Shares

$5.78 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.41M
Shares

$2.21 Million
0.21% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.78M
Shares

$1.64 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.76M
Shares

$1.62 Million
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account